drugset / Trial / NCT05309928

Phase 1 Study of the Pharmacokinetics of Amoxicillin in Pregnancy

NCT05309928

Phase 1 Completed 13 enrolled University of Alabama at Birmingham
NaSingle-groupOpen-labelBasic science

Summary

The study design is a prospective phase I pharmacokinetic study focused on dosing of 500 mg oral amoxicillin administration in pregnant women in the 2nd and 3rd trimester.

Timeline

Start
2023-08-29
Primary completion
2025-01-16
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 500 mg Oral

Indications